- Home
- IGR vs IRMD Comparison
IGR vs IRMD Comparison
Compare IGR & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGR
- IRMD
- Stock Information
- Founded
- IGR 2004
- IRMD 1992
- Country
- IGR United States
- IRMD United States
- Employees
- IGR N/A
- IRMD N/A
- Industry
- IGR Finance Companies
- IRMD Medical/Dental Instruments
- Sector
- IGR Finance
- IRMD Health Care
- Exchange
- IGR Nasdaq
- IRMD Nasdaq
- Market Cap
- IGR 770.8M
- IRMD 618.5M
- IPO Year
- IGR N/A
- IRMD 2014
- Fundamental
- Price
- IGR $4.95
- IRMD $54.65
- Analyst Decision
- IGR
- IRMD Strong Buy
- Analyst Count
- IGR 0
- IRMD 1
- Target Price
- IGR N/A
- IRMD $60.00
- AVG Volume (30 Days)
- IGR 747.7K
- IRMD 48.1K
- Earning Date
- IGR 01-01-0001
- IRMD 02-06-2025
- Dividend Yield
- IGR 13.93%
- IRMD 1.10%
- EPS Growth
- IGR N/A
- IRMD 13.16
- EPS
- IGR N/A
- IRMD 1.46
- Revenue
- IGR N/A
- IRMD $71,305,130.00
- Revenue This Year
- IGR N/A
- IRMD $13.29
- Revenue Next Year
- IGR N/A
- IRMD $10.76
- P/E Ratio
- IGR N/A
- IRMD $37.43
- Revenue Growth
- IGR N/A
- IRMD 13.23
- 52 Week Low
- IGR $3.88
- IRMD $40.18
- 52 Week High
- IGR $5.70
- IRMD $57.95
- Technical
- Relative Strength Index (RSI)
- IGR 24.60
- IRMD 56.00
- Support Level
- IGR $4.87
- IRMD $51.58
- Resistance Level
- IGR $5.89
- IRMD $54.93
- Average True Range (ATR)
- IGR 0.12
- IRMD 1.79
- MACD
- IGR -0.07
- IRMD -0.14
- Stochastic Oscillator
- IGR 8.52
- IRMD 62.40
About IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.